share_log
Benzinga ·  May 9 07:36
Applied Therapeutics Expects That Its Q1 Cash And Cash Equivalents Of $146.5M Will Fund The Business Into 2026
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment